Literature DB >> 4526298

A model for the chemotherapy of acute leukemia with 1-beta-D-arabinofuranosylcytosine.

R L Momparler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4526298

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  36 in total

1.  Accelerated radiotherapy with concomitant ACNU/Ara-C for the treatment of malignant glioma.

Authors:  K Anders; G G Grabenbauer; U Schuchardt; R Fahlbusch; R Fietkau; R Sauer; P Krauseneck
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

Review 2.  Cytosine arabinoside in the treatment of acute myeloid leukemia: the role and place of high-dose regimens.

Authors:  W Hiddemann
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

3.  Comparison of the antiviral effects of 5-methoxymethyl-deoxyuridine with 5-iododeoxyuridine, cytosine arabinoside, and adenine arabinoside.

Authors:  L A Babiuk; B Meldrum; V S Gupta; B T Rouse
Journal:  Antimicrob Agents Chemother       Date:  1975-12       Impact factor: 5.191

4.  BRAF signals to pro-apoptotic BIM to enhance AraC cytotoxicity induced in AML cells by Vitamin D-based differentiation agents.

Authors:  Xuening Wang; Jonathan S Harrison; George P Studzinski
Journal:  J Steroid Biochem Mol Biol       Date:  2016-09-13       Impact factor: 4.292

5.  Effects of cytosine arabinoside on in vivo and in vitro mouse limb development.

Authors:  J M Manson; M L Dourson; C C Smith
Journal:  In Vitro       Date:  1977-07

6.  Pharmacodynamic and DNA methylation studies of high-dose 1-beta-D-arabinofuranosyl cytosine before and after in vivo 5-azacytidine treatment in pediatric patients with refractory acute lymphocytic leukemia.

Authors:  V I Avramis; R A Mecum; J Nyce; D A Steele; J S Holcenberg
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 7.  Integrated PK-PD and agent-based modeling in oncology.

Authors:  Zhihui Wang; Joseph D Butner; Vittorio Cristini; Thomas S Deisboeck
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-01-15       Impact factor: 2.745

8.  Synthesis and biological evaluation of some phosphate triester derivatives of the anti-cancer drug araC.

Authors:  B C Jones; C McGuigan; P A Riley
Journal:  Nucleic Acids Res       Date:  1989-09-25       Impact factor: 16.971

Review 9.  Clinical pharmacokinetics of cytarabine formulations.

Authors:  Akinobu Hamada; Takeo Kawaguchi; Masahiro Nakano
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

10.  Towards better combination regimens of cytarabine and FLT3 inhibitors in acute myeloid leukemia.

Authors:  Mohamed Elmeliegy; Jason Den Haese; Chetasi Talati; Meir Wetzler; William J Jusko
Journal:  Cancer Chemother Pharmacol       Date:  2020-08-03       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.